https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Cancer Biother. Radiopharm. 2007 Aug;22(4):501-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Cancer Biother. Radiopharm. 2007 Aug;22(4):501-72007-08-01 00:00:002019-02-15 09:19:40Review: dendritic cell-based vaccine in the treatment of patients with advanced melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-292007-08-01 00:00:002007-08-01 00:00:00Benefits of superficial hyperthermia treatment planning: five case studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-06-01 / Int. J. Cancer 2007 Jun;120(11):2418-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-06-01 / Int. J. Cancer 2007 Jun;120(11):2418-252007-06-01 00:00:002019-02-15 08:49:59Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-06-01 / Melanoma Res. 2007 Jun;17(3):169-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-06-01 / Melanoma Res. 2007 Jun;17(3):169-762007-06-01 00:00:002019-02-15 09:19:41Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-30 / Physiol Res 2008;57(3):459-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-30 / Physiol Res 2008;57(3):459-652007-05-30 00:00:002007-05-30 00:00:00Immunological response in the mouse melanoma model after local hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-20 / J Transl Med 2007 Apr;5:19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-20 / J Transl Med 2007 Apr;5:192007-04-20 00:00:002019-02-15 09:19:42Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-01 / J Dtsch Dermatol Ges 2007 Mar;5(3):190-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-01 / J Dtsch Dermatol Ges 2007 Mar;5(3):190-62007-03-01 00:00:002019-02-15 09:19:43Dendritic cell-based immunotherapy of malignant melanoma: success and limitations
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-08 / Vet. J. 2008 Jan;175(1):126-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-08 / Vet. J. 2008 Jan;175(1):126-92007-01-08 00:00:002019-02-15 09:19:35Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-62007-01-01 00:00:002019-02-15 09:19:41Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Tumori 2007 Jan-Feb;93(1):26-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Tumori 2007 Jan-Feb;93(1):26-302007-01-01 00:00:002007-01-01 00:00:00Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
